Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-138809

Published: 2020

Journal Articles

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Josep Muncunill, MSc, Maria Joao Baptista, PhD PharmD, Agueda Hernandez-Rodriguez, PhD, Judith Dalmau, PhD, Gustavo Tapia, MD PhD, Olga Garcia, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Javier Martinez-Picado, PhD, Josep-Maria Ribera, MD, Evarist Feliu, MD PhD, Jose-Luis Mate, MD PhD, Jose Tomas Navarro, MD PhD

Blood (2017) 130 (Supplement 1): 4004.

https://doi.org/10.1182/blood.V130.Suppl_1.4004.4004

Published: 2017

Journal Articles

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MDPhD, Anna Sureda, MD PhD, Sara Alonso-Alvarez, MD, Ana Pilar Gonzalez, MD, Antonia Rodriguez, MD PhD, Antonio Salar, MD PhD, Fatima de la Cruz, MD, Eva Domingo, MD, Miriam Moreno, MD, Javier Lopez, Sr., MD PhD, Jose Luis Piñana, MD, Gabriela Rodriguez, Miguel Canales, Antonio Manuel Gurierrez, MD, Armando López-Guillermo, MD, María Dolores Caballero, MD PhD, Silvia Jimenez, BsC, Carmen Martinez, MD PhD

Blood (2015) 126 (23): 582.

https://doi.org/10.1182/blood.V126.23.582.582

Published: 2015

Journal Articles

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Maria Joao Baptista, PharmD, PhD, Gustavo Tapia, MD, Ana-Maria Muñoz-Marmol, PhD, Olga Garcia, MD, Josep Muncunill, MSc, Maria-Jose Terol, MD PhD, Eva González-Barca, MD PhD, Pilar Miralles, MD PhD, Ferran Vall-Llovera, MD, Mariano Provencio, MD PhD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2015) 126 (23): 3874.

https://doi.org/10.1182/blood.V126.23.3874.3874

Published: 2015

Journal Articles

Prevalence, Predictive Factors Therapy and Outcome of Patients with Follicular Lymphoma Refractory to First Line Immunochemotherapy

Marc Sorigue, MD, Juan-Manuel Sancho, Santiago Mercadal, MD, Ruben Fernández-Álvarez, MD, Helena Pomares, MD, Olga Garcia, Eva González-Barca, MD PhD, Esther González-García, MD, Miriam Moreno, MD, Cristina Motlló, MD, Montserrat García, MD, Jose-Tomas Navarro, MD PhD, Eva domingo-Domenech, MD, Evarist Feliu, MD PhD, Anna Sureda, MD PhD, Josep-Maria Ribera, MD PhD

Blood (2015) 126 (23): 1510.

https://doi.org/10.1182/blood.V126.23.1510.1510

Published: 2015

Journal Articles

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Maria Joao Baptista, PhD, Mireia Morgades, Agueda Hernandez, MD, Albert Briega, Eva Martinez, MD PhD, Javier Martinez-Picado, PhD, Guillem Sirera, MD PhD, Gustavo Tapia, MD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2014) 124 (21): 1697.

https://doi.org/10.1182/blood.V124.21.1697.1697

Published: 2014

Journal Articles

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Maria Joao Baptista, PhD, Mireia Morgades, Olga Garcia, Miriam Moreno, MD, Juan Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Josep-Maria Ribera, MD, PhD, Jose-Tomas Navarro, MD, PhD

Blood (2013) 122 (21): 1815.

https://doi.org/10.1182/blood.V122.21.1815.1815

Published: 2013

NARROW

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Prevalence, Predictive Factors Therapy and Outcome of Patients with Follicular Lymphoma Refractory to First Line Immunochemotherapy

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Email alerts

ASH Publications

American Society of Hematology

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Prevalence, Predictive Factors Therapy and Outcome of Patients with Follicular Lymphoma Refractory to First Line Immunochemotherapy

Epstein-Barr Virus Viral Loads and Serum Free Light Chains Levels Are Diagnostic Markers of Lymphoma in HIV-Infected Patients

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only